Squamous Cell Carcinoma of the Lung
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Lung.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2020-06-23Clinical Trial Update: Chemotherapy and Radiation Therapy With or Without Metformin Hydrochloride in Treating Patients With Stage III Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial assessing whether adding metformin hydrochloride to chemotherapy and radiation improves outcomes for Stage III non-small cel…
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung [Phase 1, Phase 2]
A clinical trial evaluating Glembatumumab Vedotin in gpNMB-expressing advanced or metastatic squamous cell carcinoma of the lung has been te…
-
CLINICAL_TRIALS withdrawal · 2019-02-01Clinical Trial Update: Photodynamic Therapy for the Prevention of Lung Cancer [Phase 2, Phase 3]
Phase 2/3 clinical trial investigating photodynamic therapy for prevention of lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) [Phase 3]
Phase 3 IMpower111 trial comparing atezolizumab to gemcitabine plus cisplatin or carboplatin in PD-L1-selected stage IV squamous non-small c…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease
This clinical trial update reports a pilot study evaluating Optical Frequency Domain Imaging for diagnosing central airway disease; the tria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2017-11-13Clinical Trial Update: Nab-Paclitaxel Versus Paclitaxel Plus Carboplatin in Advanced Squamous Cell Non Small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing nab-paclitaxel to paclitaxel plus carboplatin in advanced squamous cell non-small cell lung cancer; the study stat…
-
CLINICAL_TRIALS withdrawal · 2017-08-28Clinical Trial Update: Sym004 in Combination With Nivolumab Versus Nivolumab Monotherapy in EGFR-amplified Squamous Non-Small Cell Lung Cancer [Phase 1, Phase 2]
The clinical trial evaluating Sym004 in combination with nivolumab for EGFR-amplified squamous non-small cell lung cancer has been withdrawn…
-
CLINICAL_TRIALS research · 2017-08-22Clinical Trial Update: Study of Gemcitabine/Carboplatin First-line Chemotherapy +/- Apatorsen in Advanced Squamous Cell Lung Cancers [Phase 2]
A Phase 2 trial studies Gemcitabine/Carboplatin as first-line therapy with or without Apatorsen in advanced squamous cell carcinoma of the l…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens [Phase 2]
Phase 2 trial evaluating nintedanib in patients with advanced non-small cell lung cancer who progressed after up to two prior chemotherapy r…
-
CLINICAL_TRIALS research · 2017-01-25Clinical Trial Update: A Study Evaluating RO5479599 in Combination With Carboplatin and Paclitaxel in Participants With Advanced or Metastatic Non-Small-Cell Lung Cancer (NSCLC) of Squamous Histology [Phase 1, Phase 2]
A terminated Phase 1/2 study evaluating RO5479599 in combination with carboplatin and paclitaxel for advanced or metastatic squamous non-sma…
-
CLINICAL_TRIALS research · 2016-11-25Clinical Trial Update: A Study of Pemetrexed Plus Cisplatin With Concurrent Radiation Therapy Followed by Docetaxel Consolidation in Patients With Inoperable Squamous Cell Lung Cancer [Phase 2]
This clinical trial update describes a Phase 2 study of pemetrexed plus cisplatin with concurrent radiation therapy followed by docetaxel co…
-
CLINICAL_TRIALS withdrawal · 2016-11-04Clinical Trial Update: A Study of RO5083945 in Combination With Cisplatin and Gemcitabine or Carboplatin and Paclitaxel in Patients With Advanced or Recurrent Non-Small Cell Lung Cancer of Squamous Histology Who Have Not Received Prior Chemotherapy for The Metastatic Disease [Phase 1]
A Phase 1 study of RO5083945 in combination with cisplatin and gemcitabine or carboplatin and paclitaxel for squamous non-small cell lung ca…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
The PEPITA observational study evaluating erlotinib (Tarceva) in second-line squamous non-small cell lung cancer has completed.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy [Phase 2]
Phase 2 study evaluating MK-2206 with erlotinib in advanced non-small cell lung cancer patients who progressed after prior erlotinib; the tr…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating Onartuzumab (MetMAb) plus paclitaxel and platinum versus placebo in squamous non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Avastin (bevacizumab) with platinum-based chemotherapy for advanced or recurrent squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin [Phase 3]
Phase 3 trial evaluates first-line treatment with necitumumab plus gemcitabine and cisplatin in stage IV squamous non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin [Phase 3]
Phase 3 trial evaluating ipilimumab plus paclitaxel and carboplatin versus placebo in squamous non-small cell lung cancer; study completed w…
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study update for BIND-014, a docetaxel nanoparticle formulation, in second-line non-small cell lung cancer (KRAS-positive and squamo…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung [Phase 2]
Phase 2 trial evaluating REOLYSIN in combination with paclitaxel and carboplatin for metastatic or recurrent squamous cell carcinoma of the …
-
CLINICAL_TRIALS research · 2016-01-28Clinical Trial Update: Autologous Natural Killer T Cells Infusion for the Treatment of Cancer [NA]
Clinical trial update on autologous natural killer T cell infusion for cancer with unknown status at this time.
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer [Phase 3]
A Phase 3 study comparing nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2015-10-30Clinical Trial Update: Selinexor and Docetaxel in Treating Patients With Recurrent or Metastatic Squamous Cell Lung Cancer [Phase 1, Phase 2]
A clinical trial evaluating the combination of selinexor and docetaxel for recurrent or metastatic squamous cell lung cancer has been withdr…
-
CLINICAL_TRIALS withdrawal · 2015-03-19Clinical Trial Update: Phase I IGART Study Using Active Breathing Control and Simultaneous Boost for Patients With NSCLC [Phase 1]
A Phase I study evaluating active breathing control with simultaneous boost for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS research · 2015-03-05Clinical Trial Update: Icotinib in Previously Treated Non/Light-smoking Patients With Advanced Squamous Cell Lung Cancer [Phase 2]
Phase 2 clinical trial update evaluating icotinib in previously treated, non- or light-smoking patients with advanced squamous cell lung can…